Sullivan Christopher Ryan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$21,582.59
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Sullivan Christopher Ryan

According to the SEC Form 4 filings, Sullivan Christopher Ryan, being in a position of

  1. Chief Financial Officer at Avalo Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 175178 shares for $3.27M,
    over all time since 2020-06-10, has bought 9515 shares for $21,583, and sold 175178 shares for $3.27M.

Biography of Sullivan Christopher Ryan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,274,2189100

Comparison of Insiders on Amount of Buys and Sells

2026-09-16SaleAvalo Therapeutics, Inc.
AVTX
Chief Financial Officer
12,394
0.0232%
$16.33$202,437-19.57%
2026-09-10SaleAvalo Therapeutics, Inc.
AVTX
Chief Financial Officer
10,185
0.0199%
$17.62$179,457-20.93%
2026-08-18SaleAvalo Therapeutics, Inc.
AVTX
Chief Financial Officer
31,031
0.0601%
$20.05$622,324-21.87%
2026-08-17SaleAvalo Therapeutics, Inc.
AVTX
Chief Financial Officer
41,694
0.0952%
$19.86$828,096-22.46%
2026-05-06SaleAvalo Therapeutics, Inc.
AVTX
Chief Financial Officer
47,000
0.3852%
$20.19$948,722-21.23%
2026-04-30SaleAvalo Therapeutics, Inc.
AVTX
Chief Financial Officer
8,457
0.075%
$13.23$111,853+27.46%
2026-04-29SaleAvalo Therapeutics, Inc.
AVTX
Chief Financial Officer
8,458
0.0743%
$13.09$110,736+27.92%
2026-04-02SaleAvalo Therapeutics, Inc.
AVTX
Chief Financial Officer
7,980
0.0725%
$17.15$136,823-8.42%
2026-04-01SaleAvalo Therapeutics, Inc.
AVTX
Chief Financial Officer
7,979
0.0709%
$16.77$133,770-2.57%
2023-06-09PurchaseAvalo Therapeutics, Inc.
AVTX
Chief Financial Officer
511
0.0037%
$3.42$1,748-98.3%
2021-12-10PurchaseAvalo Therapeutics, Inc.
AVTX
Chief Accounting Officer
955
0.0006%
$1.57$1,499-74.37%
2020-12-10PurchaseAvalo Therapeutics, Inc.
AVTX
Interim CFO
5,095
0.003%
$2.28$11,606+1.84%
2020-06-10PurchaseAvalo Therapeutics, Inc.
AVTX
Interim CFO
2,954
0.0018%
$2.28$6,729-1.31%
Total: 13
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.